268 related articles for article (PubMed ID: 32589736)
1. What to Expect from Antibody Assays of SARS-CoV-2?
Yi X; Cao J
J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
[No Abstract] [Full Text] [Related]
2. Serum IgA, IgM, and IgG responses in COVID-19.
Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
[No Abstract] [Full Text] [Related]
3. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.
Al-Tawfiq JA; Memish ZA
Travel Med Infect Dis; 2020; 37():101785. PubMed ID: 32534208
[No Abstract] [Full Text] [Related]
4. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
[TBL] [Abstract][Full Text] [Related]
7. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
[No Abstract] [Full Text] [Related]
8. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
Greene DN
J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
[TBL] [Abstract][Full Text] [Related]
9. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.
Wu AHB
J Appl Lab Med; 2020 Sep; 5(5):1107-1110. PubMed ID: 32609341
[No Abstract] [Full Text] [Related]
10. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
11. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
[No Abstract] [Full Text] [Related]
12. Diagnostic testing for SARS-CoV-2.
Boodman C; Lagacé-Wiens P; Bullard J
CMAJ; 2020 Jun; 192(26):E713. PubMed ID: 32493742
[No Abstract] [Full Text] [Related]
13. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity.
Pancrazzi A; Magliocca P; Lorubbio M; Vaggelli G; Galano A; Mafucci M; Duranti D; Cortesi M; Mazzeschi E; Fabbroni S; Viti G; Tartaglia Polcini A; Tripodo E; Sanchini P; Gervino S; Tacconi D; Dei S; Mazzierli M; D'Urso A; Ognibene A
Clin Biochem; 2020 Oct; 84():87-92. PubMed ID: 32702365
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2.
Decru B; Van Elslande J; Weemaes M; Houben E; Empsen I; André E; Van Ranst M; Lagrou K; Vermeersch P
Clin Chem Lab Med; 2020 Sep; 58(10):e197-e199. PubMed ID: 32628628
[No Abstract] [Full Text] [Related]
16. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?
Thevis M; Knoop A; Schaefer MS; Dufaux B; Schrader Y; Thomas A; Geyer H
Drug Test Anal; 2020 Jul; 12(7):994-997. PubMed ID: 32386354
[No Abstract] [Full Text] [Related]
17. Covid-19 antibody tests: a briefing.
Baraniuk C
BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
[No Abstract] [Full Text] [Related]
18. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 serologic testing: FAQs and caveats.
Kadkhoda K
Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
[No Abstract] [Full Text] [Related]
20. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
[No Abstract] [Full Text] [Related]
[Next] [New Search]